Evidence map›Paper›PMID 32767220›Full record

ReviewGeroScience2020

Role of B cells and the aging brain in stroke recovery and treatment.

E B Engler-Chiurazzi, K L Monaghan, E C K Wan, X Ren

Open access · greenAbstract readReview
In one paragraph

Review in GeroScience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Neuroimmune Mechanisms and Emerging Intervention Strategies for Post-Stroke Fatigue: A Narrative Review.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Updates of the role of B-cells in ischemic stroke.Frontiers in cellular neuroscience · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. Leveraging single-cell RNA sequencing to unravel the impact of aging on stroke recovery mechanisms in mice.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

E B Engler-ChiurazziDepartment of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, 26506, USA. elengler@hsc.wvu.edu.ORCID 0000-0002-7656-1192
K L MonaghanCenter for Basic & Translational Stroke Research, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, 26506, USA.
E C K WanDepartment of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, 26506, USA.
X RenDepartment of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, 26506, USA.
West Virginia University · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI JUDITH FEINBERG · 2012 to 2026
$81.0M
West Virginia University Stroke COBREP20GM109098 · NIGMS · WEST VIRGINIA UNIVERSITY · PI HRUSKA, MARTIN · 2014 to 2024
$24.5M
Therapeutic use of bryostatin-1 to extend tPA time window following MCAOR01NS099918 · NINDS · WEST VIRGINIA UNIVERSITY · PI HUBER, JASON D · 2017 to 2021
$1.6M
Assessment of Mechanisms Underlying B Cell Impacts on Resilience and Susceptibility to StressK01MH117343 · NIMH · WEST VIRGINIA UNIVERSITY · PI ENGLER-CHIURAZZI, ELIZABETH · 2020 to 2023
$576k
NIGMS NIH HHS P20 GM109098NIGMS NIH HHS U54 GM104942NIMH NIH HHS K01 MH117343NINDS NIH HHS NIH R01 NS099918NINDS NIH HHS R01 NS099918
6 · The paper itself

Abstract

As mitigation of brain aging continues to be a key public health priority, a wholistic and comprehensive consideration of the aging body has identified immunosenescence as a potential contributor to age-related brain injury and disease. Importantly, the nervous and immune systems engage in bidirectional communication and can exert profound influence on each other. Emerging evidence supports numerous impacts of innate, inflammatory immune responses and adaptive T cell-mediated immunity in neurological function and diseased or injured brain states, such as stroke. Indeed, a growing body of evidence supports key impacts of brain-resident immune cell activation and peripheral immune infiltration in both the post-stroke acute injury phase and the long-term recovery period. As such, modulation of the immune system is an attractive strategy for novel therapeutic interventions for a devastating age-related brain injury for which there are few readily available neuroprotective treatments or neurorestorative approaches. However, the role of B cells in the context of brain function, and specifically in response to stroke, has not been thoroughly elucidated and remains controversial, leaving our understanding of neuroimmune interactions incomplete. Importantly, emerging evidence suggests that B cells are not pathogenic contributors to stroke injury, and in fact may facilitate functional recovery, supporting their potential value as novel therapeutic targets. By summarizing the current knowledge of the role of B cells in stroke pathology and recovery and interpreting their role in the context of their interactions with other immune cells as well as the immunosenescence cascades that alter their function in aged populations, this review supports an increased understanding of the complex interplay between the nervous and immune systems in the context of brain aging, injury, and disease.

Indexed as

AgedB-LymphocytesBrainBrain IschemiaHumansImmune SystemRecovery of FunctionStrokeStroke RehabilitationAgingB cellNeuroimmunologyStroke

Identifiers

PMID32767220
PMCPMC7525651
OpenAlexW3048167401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.